LONDON (Alliance News) - British drugmaker GlaxoSmithKline is investigating claims of improper conduct related to its business in Iraq, less than a year after China accused Glaxo of engaging in a bribery scheme aimed at increasing drug sales there, the New York Times reports.
The Wall Street Journal quoted a person familiar with the matter saying that Glaxo was violating US and UK antibribery laws by hiring government-paid physicians to promote its products in Iraq and paying for them to attend international conferences.
The New York Times quoted Glaxo spokesman Stephen Rea saying that the company employed fewer than 60 people in Iraq and that the claims related to a ?small number of individuals.?
http://www.nytimes.com/2014/04/07/business/international/glaxo-starts-investigating-possible-iraq-misconduct.html?hpw&rref=business&_r=0
By Steve McGrath; stevemcgrath@alliancenews.com; @SteveMcGrath1
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Glaxosmithkline (GSK)